| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |